LINC00402

Across TCGA pan-cancer cohorts, LINC00402 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LINC00402’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC00402 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00402 is over-expressed in tumor, although a few such as COAD and LIHC show the opposite, repressed pattern.

COAD, LIHC, and BLCA are the cancer types where LINC00402 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00402 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	−0.288	<.001	11	view →
LIHC	All	II,III,IV	−0.242	<.001	7	view →
BLCA	All	All	−0.278	.007	6	view →
BRCA	All	II,III,IV	+0.107	.003	4	view →
PRAD	All	All	+0.373	<.001	2	view →
CHOL	All	All	−0.356	.001	2	view →
THCA	All	All	−0.292	.003	2	view →
LUAD	All	All	+0.191	.010	2	view →
LUSC	All	All	−0.123	.020	1	view →
KIRC	Female	IV	−0.071	.016	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LINC00402–COAD

Open the COAD breakdown →